Terms: = Bone cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Diagnosis
19 results:
1. Association Between Insurance Status and Chondrosarcoma Stage at diagnosis in the United States: Implications for Detection and Outcomes.
Yatham P; Garcia J; Fagundo V; Castro G; Rodriguez de la Vega P; Ruiz JG; Belzarena AC
J Am Acad Orthop Surg; 2023 Feb; 31(4):e189-e197. PubMed ID: 36730695
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract] [Full Text] [Related]
3. Role of PSA Kinetics in Hormone-refractory Prostate cancer.
Sabur V; Untan I; Tatlisen A
J Coll Physicians Surg Pak; 2021 Jun; 31(6):673-678. PubMed ID: 34102779
[TBL] [Abstract] [Full Text] [Related]
4. Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
Xiao J; Wang D; Guo B; Wang L; Su M; Xu H
Nucl Med Commun; 2020 Sep; 41(9):942-949. PubMed ID: 32796483
[TBL] [Abstract] [Full Text] [Related]
5. On point in primary CNS lymphoma.
Tsang M; Cleveland J; Rubenstein JL
Hematol Oncol; 2020 Dec; 38(5):640-647. PubMed ID: 32510610
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of Progression Patterns and Failure Sites of Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Receiving First-line Treatment of Tyrosine Kinase Inhibitors.
Li XY; Zhu XR; Zhang CC; Yu W; Zhang B; Shen TL; Zhang HY; Fu XL
Clin Lung Cancer; 2020 Nov; 21(6):534-544. PubMed ID: 32505632
[TBL] [Abstract] [Full Text] [Related]
7. Patterns of metastases of prostatic ductal adenocarcinoma.
Ranasinghe WKB; Brooks NA; Elsheshtawi MA; Davis JW; Bathala TK; Tang C; Troncoso P; Aparicio A; Tu SM; Pisters LL; Chapin BF
Cancer; 2020 Aug; 126(16):3667-3673. PubMed ID: 32453443
[TBL] [Abstract] [Full Text] [Related]
8. Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.
Autore F; Strati P; Laurenti L; Ferrajoli A
Haematologica; 2018 Jun; 103(6):931-938. PubMed ID: 29748447
[TBL] [Abstract] [Full Text] [Related]
9. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract] [Full Text] [Related]
11. The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.
Bumbea H; Vladareanu AM; Vintilescu A; Radesi S; Ciufu C; Onisai M; Baluta C; Begu M; Dobrea C; Arama V; Streinu-Cercel A; Arama S
J Med Life; 2011 Aug; 4(3):256-63. PubMed ID: 22567048
[TBL] [Abstract] [Full Text] [Related]
12. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Morris PG; Ulaner GA; Eaton A; Fazio M; Jhaveri K; Patil S; Evangelista L; Park JY; Serna-Tamayo C; Howard J; Larson S; Hudis CA; McArthur HL; Jochelson MS
Cancer; 2012 Nov; 118(22):5454-62. PubMed ID: 22517371
[TBL] [Abstract] [Full Text] [Related]
13. Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients.
Promsuwicha O; Songmuang W; Auewarakul CU
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S232-8. PubMed ID: 21721452
[TBL] [Abstract] [Full Text] [Related]
14. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
[TBL] [Abstract] [Full Text] [Related]
15. Meningeal lymphomatosis as the first manifestation of splenic marginal zone lymphoma.
Bruna J; Martínez-Yelamos S; Alonso E; Romagosa V; Arruga J; Arruga J; Domingo A; Rojas-Marcos I; Petit J; Rubio F
Int J Hematol; 2005 Jul; 82(1):63-5. PubMed ID: 16105762
[TBL] [Abstract] [Full Text] [Related]
16. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.
Hunter ZR; Branagan AR; Manning R; Patterson CJ; Santos DD; Tournilhac O; Dorfman DM; Treon SP
Clin Lymphoma; 2005 Mar; 5(4):246-9. PubMed ID: 15794857
[TBL] [Abstract] [Full Text] [Related]
17. Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia.
Catovsky D
Hematol Oncol Clin North Am; 2004 Aug; 18(4):783-94, vii. PubMed ID: 15325698
[TBL] [Abstract] [Full Text] [Related]
18. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
Matutes E; Polliack A
Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
[TBL] [Abstract] [Full Text] [Related]
19. CD79: a review.
Chu PG; Arber DA
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):97-106. PubMed ID: 11396639
[TBL] [Abstract] [Full Text] [Related]
